Which is better, UTHR or ZTS?

On the Buffett-Fit framework, United Therapeutics Corporation (UTHR) currently grades higher than ZTS — 71/100 (B grade) vs 64/100 (C). That said, "better" depends on which framework you trust — UTHR wins on Warren Buffett, Benjamin Graham, Philip Fisher, Peter Lynch, and Joel Greenblatt; ZTS wins on Charlie Munger and Terry Smith. The full pillar breakdown is on this page.

Should I buy UTHR or ZTS?

This page is an educational comparison, not investment advice. Both UTHR and ZTS are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is UTHR better than ZTS for value investing?

On the Buffett-style value-investing framework, UTHR currently grades higher — 71/100 vs 64/100, a 7-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between UTHR and ZTS on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). UTHR currently scores 71/100 (B grade); ZTS scores 64/100 (C grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, UTHR or ZTS?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. UTHR and ZTS are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, UTHR or ZTS?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are UTHR and ZTS both Healthcare stocks?

Yes — both United Therapeutics Corporation (UTHR) and Zoetis Inc. (ZTS) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this UTHR vs ZTS comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

United Therapeutics

Zoetis

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

UTHR

United Therapeutics

Market cap

$24.13B

Sector

Healthcare

ZTS

Zoetis

Market cap

$34.09B

Sector

Healthcare

Overall winner

United Therapeutics UTHR

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	UTHR	ZTS	Winner
Warren Buffett	71B	64C	UTHR
Benjamin Graham	76B	70B	UTHR
Philip Fisher	76B	61C	UTHR
Peter Lynch	62C	42D	UTHR
Joel Greenblatt	46D	43D	UTHR
Charlie Munger	64C	69B	ZTS
Terry Smith	64C	73B	ZTS

Side-by-side metrics

Metric	UTHR	ZTS
Market cap	$24.13B	$34.09B
P/E (TTM)	19.2x	11.9x
EV/EBIT	15.2x	10.8x
ROIC (TTM)	18.81%	21.79%
Gross margin	86.58%	70.75%
Net margin	40.61%	27.79%
Revenue CAGR 5y	17.22%	5.04%
EPS CAGR 5y	29.84%	8.88%
Debt / Equity	-	0.1x
Dividend yield	0.0%	2.77%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

UTHR leads on

Debt / Equity-vs 0.1x+100%
Revenue CAGR 5y17.22%vs 5.04%+71%
EPS CAGR 5y29.84%vs 8.88%+70%
Net margin40.61%vs 27.79%+32%

ZTS leads on

Dividend yield2.77%vs 0.0%+100%
P/E (TTM)11.9xvs 19.2x+38%
Market cap$34.09Bvs $24.13B+29%
EV/EBIT10.8xvs 15.2x+29%

More like UTHR

UTHR vs HALO UTHR vs LMAT UTHR vs RMD UTHR vs LLY UTHR vs HAE UTHR vs IDXX

More like ZTS

ZTS vs HALO ZTS vs LMAT ZTS vs RMD ZTS vs LLY ZTS vs HAE ZTS vs IDXX

Read the full Buffett-Brain analysis for UTHR Read the full Buffett-Brain analysis for ZTS

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.

Stock comparison

United Therapeutics

Zoetis

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

UTHR

United Therapeutics

Market cap

$24.13B

Sector

Healthcare

ZTS

Zoetis

Market cap

$34.09B

Sector

Healthcare

Overall winner

United Therapeutics UTHR

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	UTHR	ZTS	Winner
Warren Buffett	71B	64C	UTHR
Benjamin Graham	76B	70B	UTHR
Philip Fisher	76B	61C	UTHR
Peter Lynch	62C	42D	UTHR
Joel Greenblatt	46D	43D	UTHR
Charlie Munger	64C	69B	ZTS
Terry Smith	64C	73B	ZTS

Side-by-side metrics

Metric	UTHR	ZTS
Market cap	$24.13B	$34.09B
P/E (TTM)	19.2x	11.9x
EV/EBIT	15.2x	10.8x
ROIC (TTM)	18.81%	21.79%
Gross margin	86.58%	70.75%
Net margin	40.61%	27.79%
Revenue CAGR 5y	17.22%	5.04%
EPS CAGR 5y	29.84%	8.88%
Debt / Equity	-	0.1x
Dividend yield	0.0%	2.77%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

UTHR leads on

Debt / Equity-vs 0.1x+100%
Revenue CAGR 5y17.22%vs 5.04%+71%
EPS CAGR 5y29.84%vs 8.88%+70%
Net margin40.61%vs 27.79%+32%

ZTS leads on

Dividend yield2.77%vs 0.0%+100%
P/E (TTM)11.9xvs 19.2x+38%
Market cap$34.09Bvs $24.13B+29%
EV/EBIT10.8xvs 15.2x+29%

More like UTHR

UTHR vs HALO UTHR vs LMAT UTHR vs RMD UTHR vs LLY UTHR vs HAE UTHR vs IDXX

More like ZTS

ZTS vs HALO ZTS vs LMAT ZTS vs RMD ZTS vs LLY ZTS vs HAE ZTS vs IDXX

Read the full Buffett-Brain analysis for UTHR Read the full Buffett-Brain analysis for ZTS

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.